Advertisement

Pharmacy World and Science

, Volume 21, Issue 3, pp 144–146 | Cite as

Long‐term stability of morphine and bupivacaine mixture for spinal use

  • C.M. Essink-Tjebbes
  • D.M. Burger
  • M. Beelen
  • E.W. Wuis
  • Y.A. Hekster
Article

Abstract

From clinical studies it has been proven that morphine in combination with bupivacaine is applicable in cancer pain. The availability of a ready to use parental dosage form of morphine and bupivacaine is comfortable for health care workers. Stability of a morphine or a bupivacaine preparation or a combination of both in a PVC cassette or polypropylene syringe for spinal use is examined in several studies. Apart from one study no data on long‐term stability of morphine‐bupivacaine mixture is available. A forced degradation study and a shelf‐life study at room temperature (20‐25 °C) were started on morphine hydrochloride 0.2 mg/ml and bupivacaine hydrochloride 7.5 mg/ml in 50 ml sterilized glass bottles type II. The results of the stability study showed that this mixture was stable up to 18 months at room temperature, whereafter morphine showed a slight degradation (5 %) and bupivacaine remained stable.

BupivacaineDrug stabilityMorphine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Stiles ML, Tu YH, Allen LV. Stability of morphine sulphate in portable pump reservoirs during storage and simulated administration. Am J Hosp Pharm 1989;46:1404-7.Google Scholar
  2. 2.
    Roos PJ, Glerum JH, Meilink JW. Stability of morphine hydrochloride in a portable pump reservoir. Pharm Weekbl Sci 1992;14(1):23-6.Google Scholar
  3. 3.
    Caute B, Monsarrat B, Lazorthes Y, Cros J, Bastide R. The stability of morphine in isobaric and hyperbaric solutions in a drug delivery system. J Pharm Pharmacol 1988;40:644-5.Google Scholar
  4. 4.
    Duafala ME, Kleinberg ML, Nacov C, Flora KP, Hines J, Davis K, McDaniel A, Scott D. Stability of morphine sulfate in infusion devices and containers for intravenous administration. Am J Hosp Pharm 1990;47:143-6.Google Scholar
  5. 5.
    Altman L, Hopkins RJ, Ahmed S, Bolton S. Stability of morphine sulfate in Cormed III (Kalex) intravenous bags. Am J Hosp Pharm 1990;47:2040-2.Google Scholar
  6. 6.
    Jones JW, Davis AT. Stability of bupivacaine hydrochloride in polypropylene syringes. Am J Hosp Pharm 1993;50:2364-5.Google Scholar
  7. 7.
    Allen LV, Stiles ML, Wang DP, Tu YH. Stability of bupivacaine hydrochloride, epinephrine hydrochloride, and fentanyl citrate in portable infusion-pump reservoirs. Am J Hosp Pharm 1993;50:714-5.Google Scholar
  8. 8.
    Tu YH, Stiles ML, Allen VL. Stability of fentanyl citrate and bupivacaine hydrochloride in portable pump reservoirs. Am J Hosp Pharm 1990;47:2037-40.Google Scholar
  9. 9.
    Roos PJ, Glerum JH, Schroeders MJH. Effect of glucose 5% solution and bupivacaine hydrochloride on absorption of sufentanil citrate in a portable pump reservoir during storage and simulated infusion by an epidural catheter. Pharm World Sci 1993;15(6):269-75.Google Scholar
  10. 10.
    Dawson PJ, Bjorksten AR, Duncan IP, BArnes RK, Beemer GH. Stability of fentanyl, bupivacaine and adrenaline solutions for extradural infusion. Br J Anaesth 1992;68:414-7.Google Scholar
  11. 11.
    Barnes AR, Nash S. Stability of bupivacaine hydrochloride with diamorphine hydrochloride in a epidural infusion. Pharm World Sci 1995;17:87-92.Google Scholar
  12. 12.
    Brouwers JRBJ, van Doorne H, Meevis RF, Boersma FP. Stability of sufentanil citrate and sufentanil citrate/bupivacaine mixture in portable infusion pump reservoirs. Eur Hosp Pharm 1995;1(1):12-4.Google Scholar
  13. 13.
    Muller H, Biscoping J, Gips H, Tilkes F, Strunz P, Hempelmann G. Hygienische Verhältnisse und Stabilität der Medicamente bei periduraler Langzeit-Infusion mit implantierten oder externen Pumpen. Anaesthesist 1985;34:247-51.Google Scholar
  14. 14.
    Nitescu P, Hultman E, Appelgren L, Linder LE, Curelaru I. Bacteriology, drug stability and exchange of percutaneous delivery systems and antibacterial filters in long-term intrathecal infusion of opiod drugs and bupivacaine in “refractory” pain. Clin J Pain 1992;8(4):324-37.Google Scholar
  15. 15.
    Johnson CE, Christen C, Perez ME, Ma M. Compatibility of bupivacaine hydrochloride and morphine sulfate. Am J Health-Syst Pharm 1997;54:61-4.Google Scholar
  16. 16.
    Wulf H, Gleim m, Mignat C. The stability of mixtures of morphine hydrochloride, bupivacaine hydrochloride, and clonidine hydrochloride in portable pump reservoirs for the management of chronic pain syndromes. J Pain Syndrom Manage 1994;9(5):308-11.Google Scholar
  17. 17.
    Lohman JJHM, Janssen MJ, Cilissen J, Hendriks MWG, Hooymans PM, Janknegt R. Compatibility of morphine hydrochloride and bupivacaine hydrochloride in a portable pump reservoir [abstract]. Pharm Weekbl Sci 1992;14(Suppl F):F27.Google Scholar
  18. 18.
    Neels JT. Compatibility of bupivacaine hydrochloride with hydromorphone hydrochloride or morphine sulfate. Am J Hosp Pharm 1992;49:2149.Google Scholar
  19. 19.
    Holdrup L, Nielsen L, Schnor T. Treatment of post-operative pain with epidural administration of morphine and bupivacaine in Deltec cassette. Ziekenhuisfarmacie 1993;9:83.Google Scholar
  20. 20.
    Beynen et al. Protocol stabiliteitsonderzoek van geneesmiddelen in waterige oplossing. NVZA 1993.Google Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • C.M. Essink-Tjebbes
  • D.M. Burger
  • M. Beelen
  • E.W. Wuis
  • Y.A. Hekster

There are no affiliations available

Personalised recommendations